Source: Annual Congress 2004 - Comparing inhaled corticosteroids
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. A. Mulrennan, J. S. Hogg, R. C. Teoh, A. H. Morice (Cottingham, United Kingdom). Mechanisms of systemic side effects of inhaled steroids. Eur Respir J 2004; 24: Suppl. 48, 2181

Member's Comments

No comment yet.

Related content which might interest you: Effects of treatment with N-acetylcysteine or inhaled corticosteroids on inflammatory mediators in COPD-patients Source: Eur Respir J 2003; 22: Suppl. 45, 5s Year: 2003 The effect of inhaled and/or systemic corticosteroids on bone metabolism in asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 Effects of inhaled corticosteroids on asthmatic inflammation: The FeNOtype trial Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Cardioprotective effects of inhaled corticosteroid-containing combination therapy in COPD Source: Eur Respir J, 53 (2) 1802420; 10.1183/13993003.02420-2018 Year: 2019 Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma Source: Eur Respir J, 55 (1) 1901147; 10.1183/13993003.01147-2019 Year: 2020 Protective effect of inhaled glucocorticosteroids on COPD model. Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Effect of inhaled corticosteroids over glucose metabolism Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002 Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids Source: Annual Congress 2007 - Respiratory issues in primary care Year: 2007 Inflammatory phenotypes of asthma determine effect of inhaled corticosteroids on anti-viral immunity Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Treatment of COPD: comparing the effects of inhaled steroids with N-acetylcysteine Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Patterns of adherence to inhaled corticosteroids Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Source: Eur Respir J 2006; 27: 172-187 Year: 2006 The effects of addition montelukast to inhaled steroids in the regular treatment of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 262s Year: 2001 Persistent local side effects of inhaled corticosteroids in asthmatics; the possible role of GERD Source: Annual Congress 2008 - Markers and triggers of asthma Year: 2008 Co-dispensing of inhaled corticosteroids and antibiotics Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Protective effect of inhaled glucocorticosteroid and long-acting beta2-agonist combination on COPD model Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Effects of montelukast on tapering inhaled corticosteroids in patients with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 260s Year: 2001 Effects of montelukast on tapering inhaled corticosteroids in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002